Dr. Arvind Lal has revolutionised diagnostics and healthcare testing in India since he took over the reins of Dr. Lal PathLabs in 1977, a family business founded by his father. An alumnus of the Armed Forces Medical College, Dr. Lal is credited with introducing the maximum number of new tests, instruments, and Information and Communications Technology systems in the pathology test industry in India.
In 2005, Dr. Lal brought on board Dr. Om Manchanda, an alumnus of IIM-Ahmedabad with 29 years of experience across sales, marketing and general management. Dr. Om Manchanda had earlier worked for Hindustan Unilever, Monsanto and Ranbaxy. Together, their strategic vision and operational abilities helped transform Dr. Lal PathLabs into its current network of over 200 labs, more than 2,500 patient service centers and close to 6,500 sample pick-up-points.
Dr. Lal PathLabs is accredited by the College of American Pathologists, National Accreditation Board for Testing and Calibration Laboratories (NABL– 27 labs), Ministry of Science and Technology. In fact, it is the first Indian lab to receive this honour. Besides that, the company is ISO 27001:2013 certified. In FY19, the company’s labs collected 41.8 million samples from 17.6 million patients. Dr. Lal PathLabs owns the world’s largest histopathology centre and second-largest kidney biopsy centre (~1,000 biopsies daily).